n/a
Abstract Title:

The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled clinical trial.

Abstract Source:

Int J Clin Pract. 2021 Jan 14:e14022. Epub 2021 Jan 14. PMID: 33445213

Abstract Author(s):

Nafiseh Shokri-Mashhadi, Maryam Tahmasebi, Javad Mohammadi-Asl, Mehrnoosh Zakerkish, Majid Mohammadshahi

Article Affiliation:

Nafiseh Shokri-Mashhadi

Abstract:

BACKGROUND: The pathogenesis of type 2 diabetes mellitus (T2DM) is associated with chronic oxidative stress and inflammation. It is well known that the expression of some miRNAs such as miRNA-146a is upregulated in diabetic and hyperglycemic patients, whereas circulating miRNA-126 is reduced. Therefore, we aimed to determine the effects of astaxanthin (AST) supplementation on the circulating malondialdehyde (MDA) and interleukin 6 (IL-6) levels, and the expression of miR-146a and miR-126 in patients with T2DM.

METHODS: This randomized, double-blind, placebo-controlled clinical trial was conducted on 44 patients with T2DM randomly receiving 8 mg/day of oral AST (n=22) or placebo (n=22) for eight weeks.

RESULTS: We observed that AST supplementation could decrease plasma levels of MDA and IL-6 (P <0.05) and decrease the expression level of miR-146a over time (fold change: -1/388) (P <0.05).

CONCLUSION: AST supplementation might be beneficial for improving circulating MDA and IL-6 and the down-regulation of miR-146a. However, future investigations are suggested to confirm these results.

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.